Effects of nobiletin on PhIP-induced prostate and colon carcinogenesis in F344 rats

Nutrition and Cancer

Volumn 63, Issue 2, 2011, Pages 227-233

  Tang, Ming Xi ^a,b   Ogawa, Kumiko ^a   Asamoto, Makoto ^a   Chewonarin, Teera ^c   Suzuki, Shugo ^a   Tanaka, Takuji ^d   Shirai, Tomoyuki ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

^c Faculty of Medicine Chiang Mai University   (Thailand)

^d KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; ESTROGEN; KI 67 ANTIGEN; LEPTIN; NOBILETIN; TESTOSTERONE;

ABERRANT CRYPT FOCUS; ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROSTATE CANCER; RAT;

ABERRANT CRYPT FOCI; ADENOCARCINOMA; ANIMALS; CARCINOGENS; CHEMOPREVENTION; COLONIC NEOPLASMS; FLAVONES; IMIDAZOLES; MALE; ORGAN SIZE; PROSTATE; PROSTATIC NEOPLASMS; RATS; RATS, INBRED F344; TESTIS;

ANIMALIA; RATTUS;

EID: 79951884253     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2011.523506     Document Type: Article

References (31)

1. Syed DN, Khan N, Afaq F, and Mukhtar H: Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev 16, 2193-2203, 2007. (Pubitemid 351196348)
2. Johnson JJ and Mukhtar H: Curcumin for chemoprevention of colon cancer. Cancer Lett 255, 170-181, 2007.
3. Takayama K, Yamashita K, Wakabayashi K, Sugimura T, and Nagao M: DNA modification by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats. Jpn J Cancer Res 80, 1145-1148, 1989. (Pubitemid 20050978)
4. Snyderwine EG, Venugopal M, and Yu M: Mammary gland carcinogenesis by food-derived heterocyclic amines and studies on the mechanisms of carcinogenesis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Mutat Res 506-507, 145-152, 2002.
5. Shirai T, Takahashi S, Cui L, Yamada Y, Tada M, et al.: Use of polyclonal antibodies against carcinogen-DNA adducts in analysis of carcinogenesis. Toxicol Lett 102-103, 441-446, 1998. (Pubitemid 29021259)
6. Takahashi S, Tamano S, Hirose M, Kimoto N, Ikeda Y, et al.: Immunohistochemical demonstration of carcinogen-DNA adducts in tissues of rats given 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): detection in paraffin-embedded sections and tissue distribution. Cancer Res 58, 4307-4313, 1998. (Pubitemid 28450031)
7. Zhu J, Chang P, Bondy ML, Sahin AA, Singletary SE, et al.: Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 12, 830-837, 2003.
8. Tang D, Liu JJ, Rundle A, Neslund-Dudas C, Savera AT, et al.: Grilled meat consumption and PhIP-DNA adducts in prostate carcinogenesis. Cancer Epidemiol Biomarkers Prev 16, 803-808, 2007. (Pubitemid 46650585)
9. Shirai T, Sano M, Tamano S, Takahashi S, Hirose M, et al.: The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res 57, 195-198, 1997. (Pubitemid 27036591)
10. Ito N, Hasegawa R, Sano M, Tamano S, Esumi H, et al.: A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-pheny limidazo[4,5-b] pyridine (PhIP). Carcinogenesis 12, 1503-1506, 1991.
11. Parkin DM, Bray FI, and Devesa SS: Cancer burden in the year 2000. The global picture. Eur J Cancer 37 (Suppl 8), S4-66, 2001.
12. Sinha R: A nepidemiologic approach to studying heterocyclic amines. Mutat Res 506-507, 197-204, 2002.
13. Nishino H, Tokuda H, Satomi Y, Masuda M, Osaka Y, et al.: Cancer prevention by antioxidants. Biofactors 22, 57-61, 2004. (Pubitemid 40921759)
14. Miyata Y, Sato T, Imada K, Dobashi A, Yano M, et al.: A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits anti-tumor metastasis in human fibrosarcoma HT-1080 cells. Biochem Biophys Res Commun 366, 168-173, 2008. (Pubitemid 350297226)
15. Tang M, Ogawa K, Asamoto M, Hokaiwado N, Seeni A, et al.: Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells. Cancer Sci 98, 471-477, 2007. (Pubitemid 46566174)
16. Luo G, Guan X, and Zhou L: Apoptotic effect of citrus fruit extract nobiletin on lung cancer cell line A549 in vitro and in vivo. Cancer Biol Ther 7, 966-973, 2008.
17. Murakami A, Nakamura Y, Torikai K, Tanaka T, Koshiba T, et al.: Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res 60, 5059-5066, 2000.
18. Minagawa A, Otani Y, Kubota T, Wada N, Furukawa T, et al.: The citrus flavonoid, nobiletin, inhibits peritoneal dissemination of human gastric carcinoma in SCID mice. Jpn J Cancer Res 92, 1322-1328, 2001. (Pubitemid 34036896)
19. Kohno H, Yoshitani S, Tsukio Y,Murakami A, Koshimizu K, et al.: Dietary administration of citrus nobiletin inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Life Sci 69, 901-913, 2001. (Pubitemid 32709643)
20. Suzuki R, Kohno H, Murakami A, Koshimizu K, Ohigashi H, et al.: Citrus nobiletin inhibits azoxymethane-induced large bowel carcinogenesis in rats. Biofactors 22, 111-114, 2004. (Pubitemid 40931879)
21. Miyamoto S, Yasui Y, Tanaka T, Ohigashi H, and Murakami A: Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice. Carcinogenesis 29, 1057-1063, 2008. (Pubitemid 351982252)
22. Wakabayashi K, Nagao M, Esumi H, and Sugimura T: Food-derived mutagens and carcinogens. Cancer Res (Suppl) 52, 2092S-2098S, 1992.
23. Asamoto M, Hokaiwado N, Cho YM, Takahashi S, Ikeda Y, et al.: Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent. Cancer Res 61, 4693-4700, 2001. (Pubitemid 32691878)
24. Kandori H, Suzuki S, Asamoto M, Murasaki T, Mingxi T, et al.: Influence of atrazine administration and reduction of calorie intake on prostate carcinogenesis in probasin/SV40 T antigen transgenic rats. Cancer Sci 96, 221-226, 2005. (Pubitemid 40767059)
25. McLellan EA and Bird RP: Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res 48, 6187-6192, 1988. (Pubitemid 18266821)
26. Sinha R, Rothman N, Brown ED, Salmon CP, Knize MG, et al.: High concentrations of the carcinogen 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine (PhIP) occur in chicken but are dependent on the cooking method. Cancer Res 55, 4516-4519, 1995.
27. Mori H, Yamada Y, Kuno T, and Hirose Y: Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis. Mutat Res 566, 191-208, 2004. (Pubitemid 38472027)
28. Morley KL, Ferguson PJ, and Koropatnick J: Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Lett 251, 168-178, 2007. (Pubitemid 46589774)
29. Zhou CH, Wu XH, and Wu YQ: Nobiletin, a dietary phytochemical, inhibits vascular smooth muscle cells proliferation via calcium-mediated c-Jun N-terminal kinases pathway. Eur J Pharmacol 615, 55-60, 2009.
30. Suzuki T, Fujimoto N, Kitamura S, and Ohta S: Quantitative determination of lobe specificity of mRNA expression of androgen-dependent genes in the rat prostate gland. Endocr J 54, 123-132, 2007. (Pubitemid 46481680)
31. Lin N, Sato T, Takayama Y, Mimaki Y, Sashida Y, et al.: Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochem Pharmacol 65, 2065-2071, 2003. (Pubitemid 36629589)